The Cutaneous Lymphoma Foundation is pleased to have awarded CLARIONS Research Grants for cutaneous lymphoma research. Learn more about some of the researchers that have received the award, their research and the importance of the Foundation's CLARIONS award.
Leandro Cerchietti, MD, Assistant Professor, Weill Cornell Medical College
Rachael Clark, MD, PhD, Associate Professor, Department of Dermatology, Brigham and Women's Hospital
Patrizia Fuschiotti, PhD, Assistant Professor of Medicine, University of Pittsburgh
Sergei Koralov, PhD, Assistant Professor, New York University School of Medicine
Tae Jin Kim, PhD, Postdoctoral Scholar, Stanford University School of Medicine
John O'Malley, MD, PhD, Research Fellow/Associate Physician, Brigham and Women's Hospital
Delphine Rolland, PharmD, PhD, Research Associate, University of Pennsylvania
Stefan M. Schieke, MD, Assistant Professor, Department of Dermatology, Medical College of Wisconsin
Learn more about CLARIONS recipients research in our annual Research Reports.
The Young Investigators Award (YIA) annual award is given to support travel of a young investigator who is presenting cutaneous lymphoma-related research at either the Society for Investigative Dermatology (SID) Annual Meeting or the American Society of Hematology (ASH) Annual Meeting.
ASH Annual Meeting Recipients
Pamela B. Allen, MD, MS, Emory University School of Medicine
María Florencia Cayrol, PhD, University of Buenos Aires, Argentine
Salvia Jain, MD, New York University
Rebecca Kohnken, DVM, Ohio State University
Anjali Mishra, PhD, Ohio State University Comprehensive Cancer Center
Bethany Mundy-Bosse, PhD, PhD, Ohio State University
Giorgia Saporiti, MD, University of Milan, Italy
Tianjiao Wang, PhD, University of Michigan
EORTC Cutaneous Lymphoma Task Force Meeting Recipients
Stefan M. Schieke, MD, University of Wisconsin-Madison
SID Annual Meeting Recipients
Oleg E. Akilov, MD, PhD, University of Pittsburgh
Narin Apisanthanarax, MD, Case Western
Rachael Clark, MD, PhD, Harvard
Adèle de Masson, MD, Brigham and Women's Hospital
Carina A. Dehner, MD, Yale School of Medicine
Shamir Geller, MD, Memorial Sloan Kettering Cancer Center; Tel Aviv Medical Center
Larisa Geskin, MD, University of Pittsburgh
Amrita Goyal, MD, University of Minnesota
Filiberto Cendeno Laurent, MD, PhD, University of Pennsylvania
Karen McGinnus, MD, University of Pennsylvania
Tomomitsu Miyagaki, MD, PhD, The University of Tokyo Graduate School of Medicine, Japan
Xiao Ni, MD, PhD, MD Anderson
John T. O'Malley, MD, PhD, Harvard Medical School
Christiane Querfeld, MD, Northwestern University
Sima Rozati, MD, University Hospital Zurich - (IID YIA Recipient)
Makato Sugaya, MD, University of Tokyo, Japan
Rei Watanabe, MD, PhD, Harvard Skin Disease and Research Center, Department of Dermatology, Brigham and Women's Hospital
Chunlei Zhang, MD, PhD, MD Anderson
Research Discovers CTCL Incidence Rising in United States
The Cutaneous Lymphoma Foundation funded an important epidemiology study that shows that the number of new cases of CTCL has doubled. In this study, Drs. Vincent Criscione and Martin Weinstock of Brown University report that there are approximately 1,600 new cases of CTCL diagnosed each year in the United States. This represents over double the number of new cases in the past fifteen years.
Groundbreaking Quality of Life Research Study
Dr. Marie-France Demierre of Boston University School of Medicine, Director of Skin Oncology, collaborated with the Cutaneous Lymphoma Foundation on an extremely important study, that of our patients’ health-related quality of life. Health-related quality of life is a multidimensional term that includes the physical, functional, psychological, social health, and well-being of the individual.
Epidemiology Characterization Synonyms CTCL
BACKGROUND: The familial occurrence of mycosis fungoides (MF) has been reported only in 8 families. Recently, the HLA class II alleles DRB1* 11 and DQB1* 03 have been found to be significantly increased for patients with sporadic MF, suggesting a possible immunogenetic basis for the pathogenesis of this malignancy.
OBJECTIVE: We sought to detect familial occurrences of MF, to describe familial features, and to investigate the possible association or linkage with the HLA system in such cases.